tiprankstipranks
Solesence (SLSN)
NASDAQ:SLSN
US Market

Solesence (SLSN) Earnings Dates, Call Summary & Reports

45 Followers

Earnings Data

Report Date
May 13, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 31, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presents a balanced picture: strong commercial momentum with record revenue (+18.6%), expanded IP (patents +20%) and operational consolidation enabling future scale, but meaningful short-term profitability and operational execution issues constrained gross profit and adjusted EBITDA (~6.8%). Management has a clear corrective plan (Transform and Transcend) with concrete margin and EBITDA targets, yet near-term headwinds (inventory/yield losses, customer sell-through weakness, restructuring costs) temper the outlook.
Company Guidance
Solesence's 2026 guidance establishes a 30% gross‑margin floor and targets at least a 5‑percentage‑point increase in gross profit margin by year‑end versus 2025, with EBITDA expected to return to double digits (after 2025 adjusted EBITDA of $4.2 million, under 7% of revenue); management also expects to realize 6‑figure annual savings from facility consolidation and to increase free cash flow by reducing safety stock. For context, 2025 was a record year with $62.1 million revenue (+18.6% vs. $51.9M in 2024), full‑year gross profit of $16.1M (vs. $16.2M), Q4 revenue of $12.5M and Q4 gross profit of $3.4M (27% margin) with Q4 operating expenses of $3.2M and Q4 net income of $0.163M (vs. a $0.558M loss prior year). The company begins 2026 with just under $33M of ship‑in open orders (down from $38M a year ago), capacity to support over $200M in revenue without further major investment, a patent portfolio of more than 120 patents (+20%), plans to expand new product categories starting late Q2/early Q3 2026, and an expected international margin improvement of 10%+ beginning in 2027, while noting Q1 may be pressured by Transform and Transcend investments and weak sell‑through at one large mass‑market customer.
Record Full-Year Revenue Growth
Revenue reached a record $62.1M in 2025, up 18.6% from $51.9M in 2024, driven by a large-scale launch and 20 new brand partners.
Quarterly Margin and Profit Improvement
Q4 2025 revenue was $12.5M (roughly flat YoY). Q4 gross profit improved to $3.4M from $2.8M (+21.4%) and gross margin rose to 27% from 22% (+5 percentage points). The company reported Q4 net income of $163K versus a net loss of $558K a year earlier (swing to profitability).
Strengthened IP and Product Recognition
Patent portfolio expanded by 20% to over 120 patents. Prototype Day Mode Hero Concealer was named a finalist across four Cosmetics & Toiletries Alle Awards categories, validating innovation and market resonance.
Manufacturing Consolidation and Capacity Leverage
Consolidated from 3 facilities to 2 while maintaining on-time-in-full (OTIF) performance; management claims existing capacity can support over $200M in revenue without further major investment and expects six-figure annual savings from consolidation.
Strategic Leadership and Transformative Plan
Added a seasoned CFO (Sept 2025) and a VP of Brand Partnerships; launched 'Transform and Transcend' with four pillars (operational excellence, tech-driven expansion, capture more value, collaborative globalization). Guidance includes a 30% gross margin floor, a plan to increase gross profit margin by at least 5% in 2026 vs 2025, and a target to return EBITDA to double digits.

Solesence (SLSN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SLSN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
- / -
0
Mar 31, 2026
2025 (Q4)
- / <0.01
0.001100.00% (<+0.01)
Nov 11, 2025
2025 (Q3)
- / -0.02
0.042-138.10% (-0.06)
Jul 31, 2025
2025 (Q2)
- / 0.04
0.015146.67% (+0.02)
May 05, 2025
2025 (Q1)
- / <0.01
0.015-93.33% (-0.01)
Mar 26, 2025
2024 (Q4)
- / >-0.01
-0.04381.40% (+0.03)
Oct 30, 2024
2024 (Q3)
- / 0.04
-0.029244.83% (+0.07)
Aug 06, 2024
2024 (Q2)
- / 0.01
0.007114.29% (<+0.01)
Apr 23, 2024
2024 (Q1)
- / 0.01
-0.023165.22% (+0.04)
Mar 20, 2024
2023 (Q4)
- / -0.04
-0.04-7.50% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SLSN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 31, 2026
$0.90$0.95+5.33%
Nov 11, 2025
$2.81$2.13-24.20%
Jul 31, 2025
$3.43$2.78-18.95%
May 05, 2025
$3.09$2.82-8.74%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Solesence (SLSN) report earnings?
Solesence (SLSN) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
    What is Solesence (SLSN) earnings time?
    Solesence (SLSN) earnings time is at May 13, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SLSN EPS forecast?
          Currently, no data Available